BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1643 related articles for article (PubMed ID: 29304725)

  • 1. Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.
    Uhl MC; Muth C; Gerlach FM; Schoch GG; Müller BS
    BMC Fam Pract; 2018 Jan; 19(1):3. PubMed ID: 29304725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia.
    Mc Namara KP; Breken BD; Alzubaidi HT; Bell JS; Dunbar JA; Walker C; Hernan A
    Age Ageing; 2017 Mar; 46(2):291-299. PubMed ID: 27836856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' views of using a screening tool to structure medicines use reviews for older people: findings from qualitative interviews.
    Cardwell K; Hughes CM; Ryan C
    Int J Clin Pharm; 2018 Oct; 40(5):1086-1095. PubMed ID: 29796962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Just a 'romantic idea'? A theory-based interview study on medication review implementation with pharmacy owners.
    Michel DE; Tonna AP; Dartsch DC; Weidmann AE
    Int J Clin Pharm; 2023 Apr; 45(2):451-460. PubMed ID: 36639520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care.
    Duncan P; Cabral C; McCahon D; Guthrie B; Ridd MJ
    Br J Gen Pract; 2019 Mar; 69(680):e190-e198. PubMed ID: 30745357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated primary care insomnia management in Australia.
    Sake FT; Wong K; Bartlett DJ; Saini B
    Res Social Adm Pharm; 2018 Feb; 14(2):170-179. PubMed ID: 28262515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.
    Hossain LN; Fernandez-Llimos F; Luckett T; Moullin JC; Durks D; Franco-Trigo L; Benrimoj SI; Sabater-Hernández D
    BMJ Open; 2017 Sep; 7(9):e015471. PubMed ID: 28877940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians.
    Lauffenburger JC; Vu MB; Burkhart JI; Weinberger M; Roth MT
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):129-38. PubMed ID: 22284582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in continuity of medication management upon transition between primary and secondary care: patients' and professionals' experiences.
    Foulon V; Wuyts J; Desplenter F; Spinewine A; Lacour V; Paulus D; De Lepeleire J
    Acta Clin Belg; 2019 Aug; 74(4):263-271. PubMed ID: 29932849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
    Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S
    Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient views about polypharmacy medication review clinics run by clinical pharmacists in GP practices.
    Snell R; Langran T; Donyai P
    Int J Clin Pharm; 2017 Dec; 39(6):1162-1165. PubMed ID: 29022166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators for providing self-care advice in community pharmacies: a qualitative study.
    Lelie-van der Zande R; Koster ES; Teichert M; Bouvy ML
    Int J Clin Pharm; 2023 Jun; 45(3):758-768. PubMed ID: 37029859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.